T he ability to detect objects at low contrast (contrast sensitivity) is a fundamental aspect of visual performance and is closely related to the ability to perform tasks such as driving, 1 2 reading 3-6 and navigation. [6] [7] [8] [9] Evidence also suggests that contrast sensitivity may help in detecting and monitoring ocular diseases such as glaucoma, 10 cataract 11 and optic neuritis. 12 Contrast sensivity can also be used in evaluating outcomes of refractive surgery. 13 Measuring contrast sensitivity provides additional information on the quality of vision and as such is recommended for use in low vision clinics. 14 However, contrast sensitivity is not widely measured in UK optometric practice. 15 We speculate that one reason for this may be the size of the Pelli-Robson chart.
The Pelli-Robson chart is wall mounted (measuring 60685 cm) and viewed at 1 m, with the subject wearing an addition of +0.75 DS over the distance refractive correction. The chart uses the 10 Sloan letters i with constant size. The letters are arranged in 16 triplets over 8 lines, where each line consists of 2 sets of triplets all of constant size. 16 In our experience, it can be difficult to ensure even illumination across the entire chart. Further, only two versions of the chart are available, meaning that its use is limited when repeated measures of contrast sensitivity are required (such as in longitudinal studies) or when measurement of each eye individually and a binocular reading are required.
Two new contrast sensitivity charts have recently been made commercially available.
First, the Mars letter contrast sensitivity chart has been developed by Dr Aries Arditi of Lighthouse Institute in New York, USA. This chart is hand-held (measuring 23636 cm) and can be stored in a protective wallet. The contrast range is from 0.04 to 1.92 log units, with each letter representing an increment of 0.04 log units. Unlike the Pelli-Robson chart, the letters are not arranged in triplets of equal contrast, but instead each successive letter decreases in contrast by 0.04 log units. The Mars chart comes in three versions, each with a different sequence of Sloan letters. The Mars chart is hand-held and viewed from 41-59 cm, and a spectacle addition of +2.00 DS is required to correct for the working distance. 17 A recent review of the Mars chart by Dougherty et al 18 showed good agreement with the Pelli-Robson chart (95% limits of agreement ¡0.21 log units), as well as good repeatability (95% limits of agreement ¡0.20 log units). Their results showed that subjects with poorer contrast sensitivity scored better on the Mars charts than on the Pelli-Robson chart. It was also found that subjects with low vision had a slightly better repeatability with the Mars chart than with the Pelli-Robson chart, although subjects with normal vision had a better repeatability with the Pelli-Robson chart. Subtle differences in the contrast levels on the different versions of the Mars charts were found. It seemed that some individual letters on certain charts (chart 3) had a different contrast value than what was actually stated. However, when adjustments to these differences were made, the Mars test resulted in a greater repeatability. 18 Another study by Haymes et al 19 investigating the reliability, validity and responsiveness of the Mars letter chart compared with the Pelli-Robson chart indicated that the Mars test has test-retest reliability equal to or better than the Pelli-Robson test. However, they also found systematic differences between the Mars chart and the Pelli-Robson chart, indicating the possibility that normative values were likely to be different for each test.
Second, the Test Chart 2000 has been developed by Professor David Thomson of City University, London, UK. This is a computerised comprehensive test chart system that presents optotypes on a computer monitor. The Test Chart 2000 contrast sensitivity test is similar to the Pelli-Robson test. For example, the chart is viewed at 1 m with the subject wearing an addition of +0.75DS. Each triplet of letters also has the same contrast as the Pelli-Robson chart, although only one triplet is presented per line. There are no published data on the validity or reliability of testing contrast sensitivity with this system.
The purpose of this study is to compare the Mars chart and the Test Chart 2000 with the Pelli-Robson chart. The Pelli-Robson chart was chosen because it is the most frequently used chart to date in UK optometric practice. 15 
MATERIALS AND METHODS
Patients were recruited from the refraction and low vision clinics at the City Road site of Moorfields Eye Hospital, London, UK. All patients were required to have a visual acuity (VA) of 3/60 or better, to be over the age of 18 years and to speak English. Snellen acuity was recorded as this information was obtained from the refraction and low vision clinics. The study was reviewed by the Moorfields and Whittington local research ethics committee and informed consent was obtained from all participants before data collection.
Data collection
Participants were asked to read six letter charts: two different Pelli-Robson charts, two different Mars charts and two different presentations on the Test Chart 2000. Charts were presented in a randomised order determined by a computer spreadsheet. All charts were viewed monocularly with the right eye (left eye occluded with palm of hand), using the optimum refractive correction as determined in their low vision or refraction appointment with appropriate addition for the screen distance (+0.75 DS for the Test Chart 2000 and Pelli-Robson charts; +2.00 DS for the Mars chart). Testing took place in a quiet clinical room. Illumination was provided for the room by overhead fluorescent tubes. No local lighting was used in order to ensure a minimum shadow in the room.
For all tests, patients were asked to read all letters starting with the highest contrast letters. Subjects were encouraged to guess and sufficient time was given to read each letter. 20 Patients were reminded not to move closer to the chart; however, head movements sideways were allowed. A response of a letter ''C'' for an ''O'' or vice versa was marked correct. 21 The Pelli-Robson test (Haag-Streit, Harlow, UK) was wallmounted and patients were tested at 1 m. Pelli-Robson scoring sheets were used to determine the contrast sensitivity. The ''letter-by-letter'' scoring system was used, whereby each letter correctly identified was scored as 0.05 log units (except for the first triplet, where contrast is 100%). 21 Testing ended when the patient missed two of three letters in a triplet. Mean chart luminance, measured using a photocolourimeter (Minolta CS100, Konica Minolta, Osaka, Japan), was 87 cd/m 2 .
The Mars Letter Contrast Sensitivity chart (Mars Perceptrix, Chappaqua, New York, USA) was held by the patient at 40 cm. Chart 3 was not used as Dougherty, et al 18 showed that some individual letters on this version of the chart had a different contrast value from that stated. As advised in the Mars chart manual, if a patient responded with a letter other than the 10 letters on the chart, they were advised of the restricted letter set and asked for another response. Testing ended when the patient made two consecutive letter-reading errors. The scoring sheet supplied in the Mars chart manual was used to record the contrast sensitivity. 17 The mean chart luminance was 113 cd/m 2 .
The Test Chart 2000 software (Thomson Software Solutions, Hatfield, Hertfordshire, UK) was installed on a PC (Precision 340, Dell, Texas, USA) running a supplementary liquid crystal display (LCD) monitor (Acer, Taiwan) through a standard VGA connection. Participants sat 1 m away from the monitor. Scoring was identical to that on the Pelli-Robson chart. The screen was c corrected using the function provided with the Test Chart 2000 software. The chart was left on for several minutes before testing to ensure that luminance had reached peak level. The mean screen luminance was 304 cd/m 2 .
Statistical analysis
The coefficient of repeatability for each chart was calculated using the method recommended by Bland and Altman. 22 The coefficient of repeatability describes the amount by which two measurements made on the same individual by the same instrument vary. The coefficient of repeatability is defined as being twice the SD of the differences between the two measurements using the same chart on the same individual.
For the new tests, limits of agreement with the Pelli-Robson chart were also calculated using Bland and Altman techniques. For this analysis, the mean and SD of the difference between the first reading on the new test and the mean reading on the Pelli-Robson test were calculated. Limits of agreement were expressed as mean (SD 2) of the difference. 22 JMP software V.5.1 was used for all analyses.
RESULTS
A total of 53 participants were recruited. Table 1 shows the primary diagnosis of each patient. Of these, 12 were controls (median VA 6/5; range 6/4 to 6/6) and the remaining were ophthalmology patients (median VA 6/6, interquartile range 6/4 to 6/18; range 6/4 to 6/72). Two patients were outliers (Mahalanobis distance .3.5) ii for all analyses of variability and agreement. No differences were identified between these outliers and the other participants in terms of age, VA or mean Pelli-Robson contrast sensitivity score. Our only known amblyopic observer was one of these outliers and the other was one of the patients who had age-related macular degeneration. These participants were removed from all subsequent analyses as suggested by Bland and Altman 22 and Tabachnick and Fidell. 23 Coefficient of repeatability Figure 1 shows the repeatability for each of the tests. Analysis of these graphs shows no relationship between the difference between the values and the mean, so no log transformation of the data was performed. For the Pelli-Robson chart, the coefficient of repeatability was 0.182 log units ( fig 1A) . The Mars chart had a coefficient of repeatability of 0.121 log units ( fig 1B) and the Test Chart 2000 had a coefficient of repeatability of 0.238 log units ( fig 1C) . Mahalanobis distance is a measure of the correlation between individual variables that can be used to determine the presence of outliers. A point with high Mahalanobis distance has high leverage-that is, it has a greater influence on the coefficients of the regression equation than other points. To include these points would (1) violate the assumption of normality required for these analyses and (2) potentially introduce bias from one erroneous measurement.
Limits of agreement
The limits of agreement between the Test Chart 2000 and the Pelli-Robson were substantially larger than for the Mars chart and Pelli-Robson. Post hoc examination of the data revealed inconsistencies for high contrast sensitivity values measured using the Test Chart 2000. When analysis was repeated for the subjects with contrast sensitivity (1.70, the limits of agreement were 20.33 to +0.15 log units (fig 3) .
DISCUSSION
In this study, we found the contrast sensitivity measurement to be slightly more repeatable for the Mars chart, and less repeatable for the Test Chart 2000, when compared with the Pelli-Robson chart. Our results for repeatability of the Pelli-Robson chart are similar to those found by other groups (table 2) .
Our data show that the Mars letter contrast sensitivity test may be slightly more repeatable than the Pelli-Robson chart. We also found good agreement between the Mars and the Pelli-Robson charts. This is in conflict with recent results for a similar size sample, reported by Haymes et al 19 who stated that the Mars chart measured poorer values than the Pelli-Robson chart for people with good contrast sensitivity and vice versa. However, the analysis used by Haymes is susceptible to a regression to the mean problem: as the abscissa in their paper contains only one value (the Pelli-Robson score), a high reading on one chart is statistically likely to be followed by a low reading on the other chart. Bland and Altman 22 are explicit that the x axis of these plots must contain the mean value rather than only one value, to overcome this artefact.
The Test Chart 2000 was found to be slightly less repeatable than the Pelli-Robson chart. Whether this limit of repeatability would be acceptable for routine practice would be at the discretion of the clinician and the reason for measuring contrast sensitivity. Given that the limits of agreement are more favourable for people with poorer contrast sensitivity, we suspect that the representation of low contrast levels may be suboptimal on a LCD monitor. LCD monitors have been shown to be less suitable for psychophysical measurement of contrast than cathode ray tube displays. 27 A further problem with the display we used with the Test Chart 2000 is its high luminance.
We suspect that the poorer agreement between the Test Chart 2000 and the Pelli-Robson is due to screen properties rather than the Test Chart 2000 in itself. We would advise people using the Test Chart 2000 system to measure contrast sensitivity to use a CRT monitor if accuracy of measurement is critical (eg, in a clinical trial).
The Mars chart was found to be straightforward to use as the patient could remain in the examination chair. Maintaining even illumination across its surface was not difficult. However, patients had to be instructed not to tilt the chart when reading letters near the contrast threshold. The Mars charts are considerably easier to store and to move between clinic bays than the Pelli-Robson chart.
The Test Chart 2000 is slightly less easy to add into a standard examination, as the patient must move in order to view the monitor at 1 m. The examining optometrist found the contrast sensitivity values were displayed on the screen alongside the test letters to be of benefit, removing the need for additional scoring sheets.
We did not assess subjects' preference as to which chart they found easiest to use, or that they preferred using. In a busy clinical setting, it may be that having all the tests performed on one instrument (as is possible with the Test Chart 2000) would be easier for the patient.
The assessment of contrast sensitivity is an important yet underused test. It is hoped that the availability of these new tests will encourage clinicians to incorporate contrast sensitivity into their examinations. 
